Avalo Therapeutics
Price & Volume
Stats
See moreOpen | $17.08 |
Previous Close | $16.94 |
Day Range | $16.82-$17.64 |
52W Range | $3.39-$20.71 |
Market Cap | $288.4M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $192,000 |
Revenue Growth (YoY) | -66.4% |
Gross Profit (12 Mos) | -$31.9M |
Diluted EPS | -$13.42 |
News
See moreYahoo Finance • 2 months ago
Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 2 months ago
Piper Sandler Maintains Bullish $48 Price Target on Avalo Therapeutics (AVTX)
Yahoo Finance • 2 months ago
Avalo Therapeutics Announces Completion of Enrollment in Phase 2 LOTUS Trial of AVTX-009 for the Treatment of Hidradenitis Suppurativa
Yahoo Finance • 4 months ago
Avalo Therapeutics Appoints Kevin R. Lind to Board of Directors
About
CEO | Dr. Garry A. Neil M.D. |
CFO | Mr. Christopher Ryan Sullivan CPA |
Address | 540 Gaither Road, Rockville, MD, United States, 20850 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 23 |
